{"id":"https://openalex.org/W2009763871","doi":"https://doi.org/10.1097/00004850-200111000-00008","title":"The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in period","display_name":"The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in period","publication_year":2001,"publication_date":"2001-11-01","ids":{"openalex":"https://openalex.org/W2009763871","doi":"https://doi.org/10.1097/00004850-200111000-00008","mag":"2009763871","pmid":"https://pubmed.ncbi.nlm.nih.gov/11712626"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-200111000-00008","doi":"https://doi.org/10.1097/00004850-200111000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200111000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008503803","display_name":"Marjolein L. Boshuisen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. L. Boshuisen","raw_affiliation_strings":["Department of Psychiatry, AZG, Groningen, The Netherlands","Department of Psychiatry, AZG, Groningen and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, AZG, Groningen, The Netherlands","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry, AZG, Groningen and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113735072","display_name":"Bernhard R. Slaap","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. R. Slaap","raw_affiliation_strings":["Department of Psychiatry, AZG, Groningen and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, AZG, Groningen and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038677934","display_name":"E. Vester-Blokland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405279838","display_name":"Organon (Netherlands)","ror":"https://ror.org/02388np20","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405279838"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"E. D. Vester-Blokland","raw_affiliation_strings":["NV Organon, Oss, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NV Organon, Oss, The Netherlands","institution_ids":["https://openalex.org/I4405279838"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111628774","display_name":"Johan A. den Boer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"J. A. den Boer","raw_affiliation_strings":["Department of Psychiatry, AZG, Groningen and","to Professor Dr J.A. den Boer, Department of Psychiatry, Psychiatric University Clinic of the Academic Hospital of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands Tel: +31 50 361 2056; fax: +31 50 361 9132; e-mail: [email\u00a0protected]","e-mail: [email\u00a0protected]","fax: +31 50 361 9132","to Professor Dr J.A. den Boer, Department of Psychiatry, Psychiatric University Clinic of the Academic Hospital of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands Tel: +31 50 361 2056"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, AZG, Groningen and","institution_ids":[]},{"raw_affiliation_string":"to Professor Dr J.A. den Boer, Department of Psychiatry, Psychiatric University Clinic of the Academic Hospital of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands Tel: +31 50 361 2056; fax: +31 50 361 9132; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +31 50 361 9132","institution_ids":[]},{"raw_affiliation_string":"to Professor Dr J.A. den Boer, Department of Psychiatry, Psychiatric University Clinic of the Academic Hospital of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands Tel: +31 50 361 2056","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5111628774"],"corresponding_institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"],"apc_list":null,"apc_paid":null,"fwci":4.9679,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.94020753,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"16","issue":"6","first_page":"363","last_page":"368"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10786","display_name":"Maternal Mental Health During Pregnancy and Postpartum","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mirtazapine","display_name":"mirtazapine","score":1.0},{"id":"https://openalex.org/keywords/panic-disorder","display_name":"panic disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/agoraphobia","display_name":"agoraphobia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/panic-attacks","display_name":"panic attacks","score":0.7710000276565552},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.6930000185966492},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.800000011920929},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5450000166893005},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.7329999804496765},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.8939999938011169},{"id":"https://openalex.org/keywords/alternative-treatment","display_name":"alternative treatment","score":0.3149999976158142}],"concepts":[{"id":"https://openalex.org/C2777529043","wikidata":"https://www.wikidata.org/wiki/Q741713","display_name":"Panic disorder","level":3,"score":0.8422119617462158},{"id":"https://openalex.org/C2781068410","wikidata":"https://www.wikidata.org/wiki/Q421930","display_name":"Mirtazapine","level":4,"score":0.7798111438751221},{"id":"https://openalex.org/C2780712732","wikidata":"https://www.wikidata.org/wiki/Q208450","display_name":"Panic","level":3,"score":0.7693991661071777},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.685884952545166},{"id":"https://openalex.org/C2778678127","wikidata":"https://www.wikidata.org/wiki/Q174589","display_name":"Agoraphobia","level":4,"score":0.637055516242981},{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.5059491991996765},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4700043797492981},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44763362407684326},{"id":"https://openalex.org/C2776317618","wikidata":"https://www.wikidata.org/wiki/Q544006","display_name":"Anxiety disorder","level":3,"score":0.44598332047462463},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4292375445365906},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3890758454799652},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3765736520290375},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.3466084599494934},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3452005386352539},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3087725043296814},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.1349693238735199},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000078785","descriptor_name":"Mirtazapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016037","descriptor_name":"Single-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016584","descriptor_name":"Panic Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016584","descriptor_name":"Panic Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/00004850-200111000-00008","doi":"https://doi.org/10.1097/00004850-200111000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200111000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:11712626","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11712626","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/923e081e-b503-4919-9554-fea0903c3dab","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/923e081e-b503-4919-9554-fea0903c3dab","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Boshuisen, ML, Slaap, BR, Vester-Blokland, ED & den Boer, JA 2001, 'The effect of mirtazapine in panic disorder : an open label pilot study with a single-blind placebo run-in period', INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, vol. 16, no. 6, pp. 363-368.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/923e081e-b503-4919-9554-fea0903c3dab","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/923e081e-b503-4919-9554-fea0903c3dab","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 16(6), 363 - 368. LIPPINCOTT WILLIAMS & WILKINS","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320315018","display_name":"Organon BioSciences","ror":"https://ror.org/02388np20"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1515756878","https://openalex.org/W1998993955","https://openalex.org/W2009573525","https://openalex.org/W2037061841","https://openalex.org/W2049066775","https://openalex.org/W2057327764","https://openalex.org/W2061378977","https://openalex.org/W2069151316","https://openalex.org/W2074130396","https://openalex.org/W2080825784","https://openalex.org/W2088071868","https://openalex.org/W2160070901","https://openalex.org/W2227188615","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W1964968339","https://openalex.org/W2083750988","https://openalex.org/W2133315555","https://openalex.org/W1998993955","https://openalex.org/W1988522912","https://openalex.org/W1996298226","https://openalex.org/W2086033531","https://openalex.org/W1529197419","https://openalex.org/W2019504028","https://openalex.org/W3018816723"],"abstract_inverted_index":{"In":[0],"this":[1,52,161],"open":[2,162],"label":[3,163],"pilot":[4],"study,":[5],"we":[6,65],"studied":[7,66],"the":[8,38,55,67,70,78,87,92,97,125,140,156],"efficacy":[9,63,118],"of":[10,22,72,80,84,91,96,106,128,160],"mirtazapine":[11,170],"(Remeron)":[12],"in":[13,69,110,143,155,165,182],"panic":[14,23,75,85,111,166,183],"disorder.":[15,184],"Twenty-eight":[16],"patients":[17,36,81,98],"with":[18,25,44],"a":[19,45,104,121,174],"DSM-IV":[20],"diagnosis":[21],"disorder,":[24],"or":[26],"without":[27],"agoraphobia":[28],"(10":[29],"males/18":[30],"females),":[31],"were":[32,99,137],"included":[33],"and":[34,77,116,153,176],"19":[35],"completed":[37],"study.":[39,93],"The":[40,134,158],"15-week":[41],"trial":[42],"started":[43],"3-week":[46],"single-blind":[47],"placebo":[48],"run-in":[49,53],"period.":[50],"After":[51],"period,":[54],"12-week":[56],"active":[57,129],"treatment":[58,130,178],"phase":[59],"started.":[60],"As":[61],"primary":[62,115],"measures,":[64],"decrease":[68,105],"number":[71,79],"full":[73],"symptom":[74],"attacks":[76],"completely":[82],"free":[83],"during":[86],"last":[88],"3":[89],"weeks":[90],"Seventy-four":[94],"percent":[95],"considered":[100],"responders,":[101],"according":[102],"to":[103,132,172],"at":[107],"least":[108],"50%":[109],"attack":[112],"frequency.":[113],"All":[114],"secondary":[117],"measures":[119],"showed":[120],"significant":[122],"improvement":[123],"from":[124,139],"second":[126],"week":[127],"onwards":[131],"endpoint.":[133],"main":[135],"side-effects":[136,142],"different":[138],"usual":[141],"selective":[144],"serotonin":[145],"reuptake":[146],"inhibitors":[147],"(SSRIs)":[148],"(initial":[149],"drowsiness,":[150],"weight":[151],"gain":[152],"pain":[154],"legs).":[157],"results":[159],"study":[164],"disorder":[167],"suggest":[168],"that":[169],"seems":[171],"be":[173],"fast":[175],"effective":[177],"alternative":[179],"for":[180],"SSRIs":[181]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}